HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study.

AbstractBACKGROUND:
Heart failure develops after myocardial infarction and is a major cause of morbidity and mortality. The ability to direct differentiation of embryonic stem cells (ESC) towards a cardiomyogenic phenotype makes them an attractive therapeutic option for cardiac repair, but species-specific and individual-specific immunological imprinting remains a hurdle. Our aim was to ascertain whether the purported immune privilege of ESC allows for their cross-species engraftment in a clinically relevant large-animal model.
METHODS:
We studied engraftment and differentiation of cardiac-committed mouse ESC in 18 sheep in which a myocardial infarction had been induced; nine controls received medium and nine sheep (five of which were immunosuppressed) received ESC. The gain in myocardial function was measured by echocardiography 1 month after cell transplantation.
FINDINGS:
Cardiac-committed murine ESC engrafted in infarcted myocardium of immunosuppressed and immunocompetent sheep, and differentiated into mature cardiomyocytes that expressed connexins. Colonisation of the scar area by ESC was accompanied by a functional benefit of the damaged myocardium. Left-ventricular ejection fraction deteriorated in the control group by a median of 9.9% (range -20 to 0.3) relative to baseline (p=0.011) whereas in the treated group it improved by 6.6% (-5.7 to 50.8; comparison between groups p=0.002).
INTERPRETATION:
These findings obtained in a clinically relevant large-animal model of heart failure strengthen the potential therapeutic use of ESC to regenerate the severely dysfunctional myocardium and bring additional evidence for an immune privilege of these cells.
AuthorsClaudine Ménard, Albert A Hagège, Onnik Agbulut, Marietta Barro, Miguel Cortes Morichetti, Camille Brasselet, Alain Bel, Emmanuel Messas, Alvine Bissery, Patrick Bruneval, Michel Desnos, Michel Pucéat, Philippe Menasché
JournalLancet (London, England) (Lancet) 2005 Sep 17-23 Vol. 366 Issue 9490 Pg. 1005-12 ISSN: 1474-547X [Electronic] England
PMID16168783 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Animals
  • Cell Differentiation
  • Cell Division
  • Cell Lineage
  • Embryo, Mammalian (cytology)
  • Graft Survival
  • Mice
  • Myocardial Infarction (physiopathology, therapy)
  • Myocardium (cytology, metabolism)
  • Sheep
  • Stem Cell Transplantation
  • Stroke Volume

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: